Glycated hemoglobin News and Research

RSS

Losing weight and keeping it off could help stabilize or improve cardiometabolic risk factors

People who lose weight and keep it off can stabilize or even improve their cardiometabolic risk factors compared to people who regain weight, finds a new study led by researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts.

9 Oct 2019

Pre-existing mental health or substance abuse issues linked to fewer complications in diabetes

A new study has found that people with mental health or substance abuse disorders who are diagnosed with diabetes may experience less severe health complications.

25 Sep 2019

Could drinking a small amount of alcohol everyday be good for type 2 diabetes?

A new meta-analysis suggests that people with type 2 diabetes may benefit from light-to-moderate drinking, which could have a positive effect on blood glucose and fat metabolism.

18 Sep 2019

How much control is too much in type 1 diabetes?

Type 1 diabetes mellitus (T1DM) affects thousands of children, and causes high sugar levels because of low insulin production. In places with good access to medical care, blood glucose is first measured by capillary blood testing or continuous monitoring. Insulin is given as required by subcutaneous injection or insulin pump.

29 Aug 2019

Fish oils have little or no effect on risk of Type 2 diabetes

Omega-3 fats have little or no effect on risk of Type 2 diabetes according to new research from the University of East Anglia.

22 Aug 2019

Study results of a potential drug to treat Type 2 diabetes in children announced

Results of a recently completed clinical trial of a potential drug to treat Type 2 diabetes in children were announced Sunday [April 28] at the Pediatric Academic Societies 2019 meeting in Baltimore, Md. The New England Journal of Medicine also published the findings.

29 Apr 2019

Effective tooth-brushing coupled with good oral hygiene can help prevent erectile dysfunction

Men who suffer from periodontitis, a disease characterized by inflammation of the gums and damage to the structures that surround and support the teeth, are at greater risk of experiencing erectile dysfunction.

12 Mar 2019

Study uses AI to analyze risk factors in type 1 diabetes

In combination with conventional statistical methods, artificial intelligence has now been used in a study of risk factors in type 1 diabetes. The objective was to identify the most important indicators of elevated risk for cardiovascular disease and death.

6 Mar 2019

Link between dietary fatty acid intake and hypertension found to be influenced by diabetes status

Hypertension is an important public health problem that can lead to life-threatening cardiovascular events, including heart attack and stroke.

20 Feb 2019

Smoking significantly increases your biological age, study shows

Insilico Medicine, one of the leaders in artificial intelligence for drug discovery, biomarker development, digital medicine, and aging research, announced the publication of a new collaborative research paper titled "Blood Biochemistry Analysis to Detect Smoking Status and Quantify Accelerated Aging in Smokers" in Scientific Reports.

17 Jan 2019

EKF introduces new hand-held lactate analyzer for rapid sports performance monitoring

EKF, announces it will be launching its new Lactate Scout 4 hand-held lactate analyzer for fast and accurate sports performance monitoring.

From EKF Diagnostics 23 Oct 2018

Appetite-suppressant drug reduces diabetes risk and increases remission rates of blood sugar

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that the appetite-suppressant drug lorcaserin decreases risk of developing diabetes and increases the rates of remission of high blood sugar.

4 Oct 2018

Closed-loop insulin delivery system shows better results for blood sugar control in type 1 diabetes

New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Berlin, Germany, and published in The Lancet, shows that use of a hybrid day-night closed-loop insulin delivery system is better than sensor-augmented pump therapy for blood sugar control in poorly controlled type 1 diabetes.

3 Oct 2018

Diabetes patients with poor blood sugar control face highest risk of serious infections

A new study has shown that diabetes patients with the poorest control of their blood sugars face the highest risks of hospitalization and death due to infections.

26 Sep 2018

EKF’s Quo-Lab POC HbA1c analyzer meets international quality targets for diabetes testing

EKF, announces the successful evaluation of its Quo-Lab point-of-care HbA1c analyzer by the European Reference Laboratory for Glycohemoglobin.

From EKF Diagnostics 20 Jul 2018

Self-monitoring of type 2 diabetes results in considerable savings on health care costs

Self-monitoring of type 2 diabetes used in combination with an electronic feedback system results in considerable savings on health care costs especially in sparsely populated areas, a new study from the University of Eastern Finland shows.

29 Jun 2018

Single blood sample can provide adequate confirmation of diabetes

The study, published June 19 in the journal Annals of Internal Medicine, found evidence that a positive result for two standard diabetes markers in a single blood sample is a highly accurate predictor of diabetes and of major diabetes complications such as kidney disease and heart disease.

19 Jun 2018

Glooko study sheds light on use of CGM data among diabetes healthcare professionals

Glooko, the leader in diabetes data management, today announced the results of its recent study which examined diabetes healthcare professionals' use of CGM data.

16 May 2018

Siemens Healthineers and Hill-Rom join to provide comprehensive solutions for primary diabetes care

Siemens Healthineers and Hill-Rom signed a co-marketing agreement to provide a suite of point-of-care diagnostic instruments that, for the first time, enable primary healthcare providers in the U.S. to bridge gaps in diabetes care and satisfy value-based quality measures in a single office visit.

From Siemens Healthineers Point of Care Diagnostics 16 May 2018

Diabetes Care journal features comprehensive EndoBarrier meta-analysis

GI Dynamics Inc., a medical device company that is developing EndoBarrier for patients with type 2 diabetes and obesity, is pleased to announce the meta-analysis, "Effects of the Duodenal-Jejunal Bypass Liner on Glycemic Control in Type 2 Diabetic Patients with Obesity: A Meta-analysis with Secondary Analysis on Weight Loss and Hormonal Changes," by Pichamol Jirapinyo, MD, of Brigham and Women's Hospital in Boston, Massachusetts, and Diplomat of the American Board of Obesity Medicine, has been published in Diabetes Care, the journal of the American Diabetes Association.

10 May 2018